All Insights
Showing 37 - 48 of 357
Life Sciences and Healthcare
Court of Appeal upholds English High Court decision on invalidity of dapagliflozin patent and SPCs
The High Court was right to find AstraZeneca's patent and associated SPCs invalid for lack of plausibility
Life Sciences and Healthcare
EU confirms app stores and developers are subject to medical device laws
New MDCG guidelines put online stores and software developers on the medtech regulatory radar
Life Sciences and Healthcare
What does the UK government's ambitious sector plan for life sciences mean for the industry?
The plan sets out a roadmap for regulatory reform, targeted investment and strategic partnerships to drive innovation
Life Sciences and Healthcare
Navigating the Legal Landscape of Pharmaceutical Marketing on Social Media: Strategies & Risks
Social media has become an integral part of daily life, with billions of users globally, including consumers who seek health-related
Healthcare
New decision in pharmaceutical pricing – do price binding regulations not apply in cross-border online sales?
On 17 July 2025, the German Federal Court of Justice (BGH) delivered a pivotal judgment (I ZR 74/24) that will
Life Sciences and Healthcare
High Seas Treaty makes progress with global signatories at UN ocean governance summit
The UN marine biodiversity conference has helped move the treaty closer to ratification although it is not there yet
Life Sciences and Healthcare
EU guidance details how technical and clinical standards converge for AI in medtech
FAQ explains research exemption, dual conformity assessment and clinical data obligations for devices and diagnostics
Life Sciences and Healthcare
Engineering biology among 'frontier industries' named in UK industrial strategy
The technology is one of six identified in the digital and technologies sector plan to spearhead UK economic growth
Life Sciences and Healthcare
NHS 10 Year Health Plan set to hold out big opportunities for UK private sector suppliers
'Fixing the NHS' will involve easing pressure on hospitals, rapid digitalisation and investment in preventative care
Retail and Consumer
From novel to norm: UK businesses are navigating a maze of regulation around alternative proteins
Companies and manufacturers are seeking out technical advice for food law and novel products in multiple markets
Life Sciences and Healthcare
European Commission consultation shapes high-risk AI classification for life sciences in the EU
Stakeholder input will influence guidelines for AI Act implementation in healthcare and medical technologies
Intellectual property
English Patents Court grants further interim injunctions to prevent generic launch pending appeal decision on patent and SPCs' validity
This follows the Court of Appeal overturning the Patents Court to grant interim injunctions until the first instance validity judgment
